ShangPharma, a China-based R&D outsourcing company, has opened a new facility to meet the growing needs of one of its largest customers, Eli Lilly. ShangPharma also announced that it has signed a multi-year extension of its contract with Lilly. The newly opened facility adds 110,000 sq. ft. of laboratory and office space to the company’s overall capacity, and is fully dedicated to supporting Lilly’s ongoing and future projects. ShangPharma’s services consist of discovery c...